Abstract:The telomere-associated protein tankyrase is a poly(adenosine diphosphate-ribose) polymerase and is considered to be a promising target for cancer therapy, especially selective lethality on breast cancer associated (BRCA) cell lines, including breast cancer as well as malignancies of the ovaries, pancreas, and prostate gland. A variety of drug candidates have been developed and investigated, such as XAV-939, which was identified as a tankyrase inhibitor during screening for a small-molecule inhibitor of the Wnt/beta-catenin pathway, and it exhibits nanomolar activity in the tankyrase-2 biochemical assay. Coincidentally, almost all compounds which exhibit excellent activity in the tankyrase-2 biochemical assay showed the common structure: lactam ring or amide structure. According to the reported co-crystal structure of inhibitors with tankyrase-2 analysis, it was found that the lactam ring or amide of the compounds forms three conserved hydrogen bonds to Gly1032 and Ser1068 and a p-stacking interaction with Tyr1071. Thus the lactam ring or amide was identified to be a key structure of tankyrase inhibitors. So a new class of structure based on benzo[f][1,4] oxazepinone scaffold was designed through computer-aided virtual drug screening, and 12 new compounds were synthesized via Mannich reactions of aromatic aldehydes with aromatic amines and aromatic ketones, ring expansion, reduction and condensation. The target compound was confirmed by H-1 NMR, C-13 NMR, HRMS. Followed by the methyl thiazolyl tetrazolium (MTT) assay to test in vitro anti-tumor activity, part compounds showed potent inhibitory effect on tumor cells. This study culminates in compound 3h, an inhibitor with potent activity against Hep-3B (IC50 = 3.5 mu mol/L). Here, the synthesis and structure-activity relationship (SAR) of this novel series were described. To explore the anti-tumor mechanism of benzo[f][1,4] oxazepinone compounds, we explored the interaction of the compound 3h complex with the Gly1032, Ser1068 and Tyr1071 binding site of tankyrase-2, which confirms the three conserved hydrogen and p-stacking binding mode, as supporting information for the in vitro anti-tumor activity.

Correction to "Bifunctional Naphtho[2,3-d][1,2,3]triazole-4,9-dione Compounds Exhibit Antitumor Effects In Vitro and In Vivo by Inhibiting Dihydroorotate Dehydrogenase and Inducing Reactive Oxygen Species Production".

Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids.

Rational Design and Synthesis of Triazene-Amonafide Derivatives As Novel Potential Antitumor Agents Causing Oxidative Damage Towards DNA Through Intercalation Mode

Structure-based design of potent human dihydroorotate dehydrogenase inhibitors as anticancer agents

New 3-[(4-hydroxy-6-methly-2(1h)-pyridinones)-3-yl]-4-substituted-(1h)1,2,4- Triazole-5-Thiones: Efficient Synthesis, X-Ray Crystallographic Analysis, and Antitumor Activity

Structural Optimization and Structure–Activity Relationship of 4-Thiazolidinone Derivatives As Novel Inhibitors of Human Dihydroorotate Dehydrogenase

Synthesis And Biological Evaluation Of 3-Aryl-Quinoxaline-2-Carbonitrile 1,4-Di-N-Oxide Derivatives As Hypoxic Selective Anti-Tumor Agents

Synthesis and antitumor activity of dolutegravir derivatives bearing 1,2,3-triazole moieties

[Design, Synthesis and Structure-Activity Relationship Studies of Human Dihydroorotate Dehydrogenase Inhibitors].

Synthesis and antitumor activity of 4-cyclohexyl/aryl-5-(pyridin-4-yl)-2,4-dihydro-3H-1,2,4-triazole-3-thiones

Design, synthesis, and evaluation of proliferation inhibitory activity of novel L-shaped ortho-quinone analogs as anticancer agents

Design, synthesis, and evaluation of novel (E)-N'-(3-allyl-2-hydroxy)benzylidene-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides as antitumor agents

Biological Evaluation of Quinoline Derivatives As Inhibitors of Human Dihydroorotate Dehydrogenase

Design, Synthesis, and Biological Evaluation of a Novel Series of Teriflunomide Derivatives as Potent Human Dihydroorotate Dehydrogenase Inhibitors for Malignancy Treatment

Discovery of proqodine A derivatives with antitumor activity targeting NAD(P)H: quinone oxidoreductase 1 and nicotinamide phosphoribosyltransferase

Design, Synthesis, X-ray Crystallographic Analysis, and Biological Evaluation of Thiazole Derivatives As Potent and Selective Inhibitors of Human Dihydroorotate Dehydrogenase.

Synthesis, Antifolate and Anticancer Activities of N(5) -Substituted 8,10-Dideazatetrahydrofolate Analogues.

Unprecedented Synthesis, in Vitro and in Vivo Anti-Cancer Evaluation of Novel Triazolonaphthalimide Derivatives.

Discovery of novel hydroxyamidine based indoleamine 2,3-dioxygenase 1 (IDO1) and thioredoxin reductase 1 (TrxR1) dual inhibitors

Discovery a Series of Novel Inhibitors of Human Dihydroorotate Dehydrogenase: Biological Activity Evaluation and Molecular Docking.

Synthesis and Anticancer Activity Evaluation of Benzo[F][1,4] Oxazepinone Derivatives